European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- Jun 2026

To guarantee that every patient receives the identical therapeutic dose, batches must undergo mass or content uniformity profiling.

, is a general monograph that describes the individual and general quality standards for this specific dosage form. It covers everything from the physical definition—usually straight, circular solid cylinders with flat or convex surfaces—to the complex chemical and mechanical tests required for release. Key Quality Requirements European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

The European Pharmacopoeia Monograph 0478—Tablets is a cornerstone of pharmaceutical regulation in Europe and beyond. It goes far beyond a simple definition to provide a detailed, legally binding framework covering a tablet's entire lifecycle, from its design and manufacture to its final quality control. To guarantee that every patient receives the identical

Uncoated tablets must typically disintegrate in water within . Film-coated tablets are allowed up to 30 minutes . Film-coated tablets are allowed up to 30 minutes

A monograph is a detailed description of a specific medicinal product, including its composition, manufacturing process, and testing requirements. Monographs are an essential part of the Ph. Eur., as they provide a standardized approach to ensuring the quality of medicines. The monograph for Tablets - 0478 is one such monograph that sets standards for the quality of tablets.

For any batch of tablets to be released to the market, it must comply with a series of analytical tests defined in the monograph and general chapters. These tests are the pillars of quality control.

One of the most vital safety checks, this test ensures that every individual tablet contains the intended amount of API within strict tolerances. Compliance can be demonstrated via: